uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 23, 2020

BIOTA Biosciences Recalls Injectable CBD and Curcumin Products

On May 20, 2020, BIOTA Biosciences LLC issued a recall of five lots of three injectable products because they were marketed without FDA approval. The products, Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables, are also misbranded because their labels do not have appropriate directions for use.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at